Jerusalem: On Dec 29, Israel’s Oramed Pharmaceuticals announced that its Oravax Medical unit had signed a deal with Vietnam’s Tan Thanh Holdings for the pre-order of 10 million doses of its oral COVID-19. The said COVID-19 vaccine is in clinical trials. Nadav Kidron, chief executive of Oramed, said its oral COVID vaccine was undergoing Phase I clinical trials, and results should be available in early 2022.
You May Also Like
Apple alleges India’s apps of abusing power
New Delhi: On Dec 19, Apple Inc has consulted India’s antitrust watchdog…
- Alina Hashmi
- December 20, 2021
Two-day pharma and healthcare expo kickstarts
Lahore: Pak Pharma and Healthcare expo in collaboration with the Pakistan Pharmaceutical…
- Alina Hashmi
- February 16, 2023
Emirates to start Dubai-Tel Aviv daily flights
Dubai: It emerged on Thursday that Emirates will be starting daily flights…
- Alina Hashmi
- November 4, 2021
Punjab changes admission policy for medical, dental colleges
The Punjab education authorities have changed the admission policy for the government…
- Hafsa Mustafa
- October 2, 2023